Sight Diagnostics
Eylam Oron has over a decade of experience in product management, specializing in the development and launch of innovative medical devices and technology products. Eylam has held senior roles at companies such as Sight Diagnostics, Watergen Ltd, Phibro Animal Health, Alpha Bio Tec, and DNR Bio-Imaging Systems. Eylam'swork involves leading product strategy, development, and execution, managing global markets, and driving revenue growth through new product launches and portfolio enrichment. Eylam's expertise spans across hardware, software, AI, SaaS, and mobile technologies.
Eylam Oron obtained a Bachelor of Science (BSc) in Life Science from Ben-Gurion University of the Negev in 2002, followed by a Master of Science (MSc) in Life Science with a focus on Molecular Biology from the same institution in 2005. Eylam then pursued a Master of Business Administration (MBA) degree in Finance and Strategy at The Hebrew University of Jerusalem from 2010 to 2012. In 2016, Eylam attended Technion - Israel Institute of Technology to study Advanced Project Management methodologies and earn a Project Management Professional (PMP®) certification. Eylam continued their education in 2017 at the Association for the Advancement of Medical Instrumentation (AAMI) to delve into Design Control. Finally, in 2018, they completed a Certificate program in the Internet of Things: Business Implications and Opportunities at MIT Sloan Executive Education.
This person is not in any offices
Sight Diagnostics
The faster we diagnose, the faster we can treat. At Sight Diagnostics, we aim to improve health through fast, accurate and convenient diagnostic testing. Sight’s latest analyzer, Sight OLO, performs a Complete Blood Count, the most commonly ordered blood test, in minutes, not hours. It’s compact: designed to be used by anyone, anywhere. Sight’s method, developed over a decade of research, represents a step-change in diagnostic technology. Our analyzers create a digital version of your blood, by capturing 1,000 highly detailed images of a finger prick sample, which is then interpreted by our proprietary algorithms. Sight’s first product was focused on detecting Malaria, used in 24 countries, and has delivered almost 1 million tests to date. At Sight, exceptional individuals work together to achieve extraordinary things. We have rapidly growing offices in London, New York, and Tel Aviv.